Epidermal growth factor

February 10, 2022

VUMC mourns loss of former Dermatology leader King

Longtime faculty member Lloyd E. King Jr., MD, PhD, who joined Vanderbilt University Medical Center in 1977 as chief of the Division of Dermatology, died Feb. 8 at Vanderbilt University Hospital after a brief illness.

By Paul Govern
March 17, 2017

New target for colorectal cancer

Vanderbilt investigators have discovered that activated epidermal growth factor receptor may be a target for therapies to prevent colorectal cancer development.

By VUMC News and Communications
October 10, 2013

Probing mutant EGF receptor regulation

Understanding the regulation of mutant EGF receptors commonly found in lung cancers could lead to new targeted therapies.

By Leigh MacMillan
June 6, 2013

VU study identifies new mechanism for cancer development

Researchers at Vanderbilt University Medical Center led by a 32-year-old postdoctoral fellow have discovered a new mechanism for the development of cancer that is challenging conventional scientific wisdom.

By Bill Snyder